索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]张凌霄,王军奎.预测心力衰竭患者肾功能恶化血清学指标的研究进展[J].国际心血管病杂志,2016,04:207-209.
点击复制

预测心力衰竭患者肾功能恶化血清学指标的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年04期
页码:
207-209
栏目:
综述
出版日期:
2016-07-20

文章信息/Info

Title:
-
作者:
张凌霄; 王军奎
710068 西安医学院附属陕西省人民医院心血管内一科
Author(s):
-
关键词:
心力衰竭; 肾功能恶化; 血清学指标
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.04.005
文献标识码:
-
摘要:
心力衰竭(心衰)患者合并肾功能不全与临床预后密切相关,肾功能不全传统的生化标志物异常往往出现较晚,不具有早期预警价值。该文主要介绍对心衰患者发生肾功能恶化具有预测价值并和预后相关的血清学指标的最新研究进展。
Abstract:
-

参考文献/References

[1] Palazzuoli A, McCullough PA, Ronco C, et al. Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection [J]. Intern Emerg Med,2015,10(5):543-554.
[2] Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: perspectives on translation[J]. Clin J Am Soc Nephrol, 2008, 3(2):481-490.
[3] Ljungman S, Laragh JH, Cody RJ, et al, Role of the kidneyin congestive heart failure: relationship of cardiac index to kidneyfunction [J]. Drugs,1990,39(Suppl4):10-24.
[4] Ruggenenti P, Remuzzi G. Worsening kidney function in decompensated heart failure: treat the heart don't mind the kidney [J]. Eur Heart J,2011, 32(20):2476-2478.
[5] Parrinello G, Torres D, Paterna S.Salt and water imbalance in chronic heart failure [J]. Intern Emerg Med,2011,6(suppl 1):S29-S36.
[6] Ronco C, Cicoira M, McCullough PA. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in thesetting of acutely decompensated heart failure [J]. J Am Coll Cardiol,2012,60(12):1031-1042.
[7] 郭 俊,冯 灿,陆 阳,等.心肾综合征的诊治及研究进展[J].国际心血管病杂志,2015,42(1):19-22.
[8] Sinkeler SJ, Damman K, van Veldhuisen DJ, et al. A re-appraisal of volume status and renal function impairment in chronic heart failure: combined effects of pre-renal failure and venous congestion on renal function [J]. Heart Fail Rev, 2012,17(2):263-270.
[9] Bongartz LG, Cramer MJ, Doevendans PA, et al. The severe cardiorenalsyndrome: ‘Guyton revisited' [J]. Eur Heart J,2005,26(1):11-17.
[10] Bouquegneau A, Krzesinski JM, Delanaye P, et al. Biomarkers and physiopathology in the cardiorenal syndrome [J]. Clinica Chimica Acta,2015,443(30): 100-107.
[11] Kashiwagi E, Tonomura Y, Kondo C, et al. Involvement of neutrophil gelatinaseassociated lipocalin and osteopontin in renal tubular regeneration aninterstitial fibrosis after cisplatin-induced renal failure[J]. Exp Toxicol Pathol,2014,66(7):301-311.
[12] Palazzuoli A, Ruocco G, Beltrami M, et al. Admission plasma neutrophil gelatinase associated lipocalin(NGAL)predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure[J]. Acute Card Care, 2014, 16(3):93-101.
[13] Medic' B, Rovcˇanin B, Basta Jovanovic' G,et al.Kidney injury molecule-1 and cardiovascular diseases: from basic science to clinical practice[J]. Biomed Res Int,2015(2015):854070.
[14] Bonventre JV. Kidney injury molecule-1: a translational journey[J]. Trans Am Clin Climatol Assoc,2014,125:293-299.
[15] Aghel A, Shrestha K, Mullens W, et al. Serum neutrophil gelatinase-associated lipocalin(NGAL)in predicting worsening renal function in acute decompensated heart failure[J]. J Card Fail,2010,16(1):49-54.
[16] Damman K, Masson S, Hillege HL, et al. Clinical outcome of renal tubular damage in chronic heart failure[J]. Eur Heart J,2011,32(21):2705-2712.
[17] Damman K, Van Veldhuisen DJ, Navis G, et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate[J]. Heart,2010,96(16):1297-1302.
[18] Séronie-Vivien S, Delanaye P, Piéroni L, et al. Cystatin C: current position andfuture prospects[J]. Clin Chem Lab Med,2008,46(12):1664-1686.
[19] Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: incorporation into clinical practice[J]. Am J Kidney Dis,2013,62(3):595-603.
[20] Cruz DN, Fard A, Clementi A, et al. Role of biomarkers in the diagnosis and management of cardio-renal syndromes[J]. Semin Nephrol,2012,32(1):79-92.
[21] Naruse H, Ishii J, Kawai T, et al. Cystatin C in acute heart failure without advanced renal impairment[J]. Am J Med,2009,122(6):566-573.
[22] 吴 敏,韩素霞.血清胱抑素C与心力衰竭[J].国际心血管病杂志,2014,41(6):356-358.
[23] Parrinello G, Torres D, Testani JM, et al. Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction[J].Intern Emerg Med,2015,10(8):965-972.
[24] Brisco MA, Coca SG, Chen J, et al. Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure[J]. Circ Heart Fail,2013,6(2):233-239.
[25] Kazory A. Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure[J]. Am J Cardiol,2010,106(5):694-700.
[26] Sood MM,Saeed M,Lim V,et al. The urea-to-creatinine ratio is predictive of worsening kidney function in ambulatory heart failure patients[J]. J Card Fail,2015,21(5):412-418.
[27] Takaya Y,Yoshihara F,Yokoyama H,et al. Risk stratification of acute kidney injury using the blood urea nitrogen/creatinine ratio in patients with acute decompensated heart failure[J]. Circ J,2015,79(7):1520-1525.
[28] Yamazoe M,Mizuno A,Nishi Y,et al. Serum alkaline phosphatase as a predictor of worsening renal function in patients with acute decompensated heart failure[J]. J Cardiol,2016,67(5):412-417.
[29] Lau GT,Tan HC,Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation[J]. Am J Cardiol,2002,90(12):1405-1409.
[30] KarabulutA, Sahin I,Ilker Avci I,et al. Impact of serum alkaline phosphatase level on the pathophysiologic mechanism of contrast-induced nephropathy[J]. Kardiol Pol,2014,72(10):977-982.
[31] De Berardinis B,Gaggin HK,Magrini L,et al. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure[J]. Clin Chem Lab Med,2015,53(4):613-621.
[32] Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase-associated lipocalin(NGAL)in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis[J]. Am J Kidney Dis,2009,54(6):1012-1024.

备注/Memo

备注/Memo:
通信作者:王军奎,Email:cardiowang@163.com
更新日期/Last Update: 2016-07-20